APA (7th ed.) Citation

Brown, W., & Coles, A. (2013). Alemtuzumab: Evidence for its potential in relapsing-remitting multiple sclerosis. Drug design, development and therapy, 7, 131-138. https://doi.org/10.2147/DDDT.S32687

Chicago Style (17th ed.) Citation

Brown, William, and Alasdair Coles. "Alemtuzumab: Evidence for Its Potential in Relapsing-remitting Multiple Sclerosis." Drug Design, Development and Therapy 7 (2013): 131-138. https://doi.org/10.2147/DDDT.S32687.

MLA (9th ed.) Citation

Brown, William, and Alasdair Coles. "Alemtuzumab: Evidence for Its Potential in Relapsing-remitting Multiple Sclerosis." Drug Design, Development and Therapy, vol. 7, 2013, pp. 131-138, https://doi.org/10.2147/DDDT.S32687.